Current Neuro-Oncology
Volume
26 Number 28
10 December 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 28, 10 December
*Alanazi RF, Alharbi N, Alkhaibary A, AlSufiani F, Aloraidi A.
Benign Transformation of Atypical
Meningioma: A Rare Histopathological Phenomenon at Recurrence.
Case
Rep Surg. 2024 Dec 1;2024:4118914. doi:
10.1155/cris/4118914. PMID:
39649036. Case report. ˍ
*Weber S, Kuhl S, Goldbrunner R, Timmer M.
LET-7a
and LET-7b
as Potential Signatures for Glioma Recurrence, Regardless of WHO
Tumor Grade.
Anticancer
Res. 2024 Dec 2;44(12):5199-5205. doi:
10.21873/anticanres.17346. PMID:
39626941. Observational study. ˍ
Wu CY, Chen Y, Lin YJ, Wei KC, Chang KY, Feng LY, Chen KT, Li G,
Ren AL, Nitta RT, Wu JY, Cho KB, Pant A, Choi J, Mackall CL, Kim
LH, Wu AC, Chuang JY, Huang CY, Jackson CM, Chen PY, Lim M.
Tumor-Associated Microglia Secrete
Extracellular ATP to Support Glioblastoma Progression.
Cancer
Res. 2024 Dec 2;84(23):4017-4030. doi:
10.1158/0008-5472.CAN-24-0018. PMID:
39618248. Laboratory investigation˰
ˍ
Lamoureux AA, Fisher MJ, Lemelle L, Pfaff E, Amir-Yazdani P, Kramm
C, De Wilde B, Kazanowska B, Hutter C, Pfister SM, Sturm D, Jones
DTW, Orbach D, Pierron G, Raskin S, Drilon A, Diamond EL, Harada
G, Zapotocky M, Zamecnik J, Krskova L, Ellezam B, Weil AG, Venne
D, Barritault M, Leblond P, Coltin H, Hammad R, Tabori U, Hawkins
C, Hansford JR, Meyran D, Erker C, McFadden K, Sato M, Gottardo
NG, Dholaria H, Nørøxe DS, Goto H, Ziegler DS, Lin
FY, Parsons DW, Lindsay H, Wong TT, Liu YL, Wu KS, Franson AT,
Hwang E, Aguilar-Bonilla A, Cheng S, Cacciotti C, Massimino M,
Schiavello E, Wood P, Hoffman LM, Cappellano A, Lassaletta A, Van
Damme A, Llort A, Gerber NU, Spalato Ceruso M, Bendel AE, Skrypek
M, Hamideh D, Mushtaq N, Walter A, Jabado N, Alsahlawi A, Farmer
JP, Coleman C, Mueller S, Mazewski C, Aguilera D, Robison NJ,
O'Halloran K, Abbou S, Berlanga P, Geoerger B, Øra I,
Moertel CL, Razis ED, Vernadou A, Ducray F, Bronnimann C, Seizeur
R, Clarke M, Resnick AC, Alves M, Jones C, Doz F, Laetsch TW,
Perreault S.
Clinical characteristics
and outcome of central nervous system tumors harboring NTRK gene
fusions.
Clin
Cancer Res. 2024 Dec 3. doi:
10.1158/1078-0432.CCR-24-0581. PMID:
39625867. Observational study. ˍ
Xue J, Zhang J, Zhu J.
Unraveling
molecular signatures and prognostic biomarkers in glioblastoma: a
comprehensive study on treatment resistance and personalized
strategies.
Discov
Oncol. 2024 Dec 4;15(1):743. doi:
10.1007/s12672-024-01649-y. PMID:
39630160. Observational study. ˍ
Duraj T, Kalamian M, Zuccoli G, Maroon JC, D'Agostino DP, Scheck
AC, Poff A, Winter SF, Hu J, Klement RJ, Hickson A, Lee DC, Cooper
I, Kofler B, Schwartz KA, Phillips MCL, Champ CE, Zupec-Kania B,
Tan-Shalaby J, Serfaty FM, Omene E, Arismendi-Morillo G, Kiebish
M, Cheng R, El-Sakka AM, Pflueger A, Mathews EH, Worden D, Shi H,
Cincione RI, Spinosa JP, Slocum AK, Iyikesici MS, Yanagisawa A,
Pilkington GJ, Chaffee A, Abdel-Hadi W, Elsamman AK, Klein P,
Hagihara K, Clemens Z, Yu GW, Evangeliou AE, Nathan JK, Smith K,
Fortin D, Dietrich J, Mukherjee P, Seyfried TN.
Clinical
research framework proposal for ketogenic
metabolic therapy in glioblastoma.
BMC
Med. 2024 Dec 5;22(1):578. doi:
10.1186/s12916-024-03775-4. PMID:
39639257. Research
design. ˍ
Nylander E, Stam F, Katila L, Zelleroth S, Birgersson J, Nyberg F,
Hallberg M, Grönbladh A.
Revisiting
opioid toxicity: Cellular effects of six commonly used opioids.
Scand
J Pain. 2024 Dec 5;24(1). doi:
10.1515/sjpain-2024-0038. PMID:
39636779. Laboratory investigation. ˍ
Yip CM, Jan CI.
A Rare Case of Dual
Primary Supratentorial Glioma and Infratentorial Meningioma.
J
Neurol Surg Rep. 2024 Dec 5;85(4):e179-e183. doi:
10.1055/a-2466-7362. PMID:
39639922. Case report. ˍ
Karimian-Jazi K, Enbergs N, Golubtsov E, Schregel K, Ungermann J,
Fels-Palesandro H, Schwarz D, Sturm V, Kernbach JM, Batra D, Ippen
FM, Pflüger I, von Knebel Doeberitz N, Heiland S, Bunse L,
Platten M, Winkler F, Wick W, Paech D, Bendszus M, Breckwoldt MO.
Differentiating Glioma Recurrence and
Pseudoprogression by APTw CEST MRI.
Invest
Radiol. 2024 Dec 9. doi:
10.1097/RLI.0000000000001145. PMID:
39644107. Interventional study˰
ˍ
Larrouquere L, Dufour C, Faure-Conter C, Alapetite C, Meyronet D,
Bolle S, Bonneville-Levard A, Sunyach MP, Laurence V, Frappaz D.
Intensive pediatric chemotherapy
regimen (PNET HR+5) in adult high-risk medulloblastoma and
pineoblastoma patients.
Neurooncol
Adv. 2024 Aug 10;6(1):vdae141. doi:
10.1093/noajnl/vdae141. PMID:
39620201. Observational study. ˍ
Manake R, Phillips V, Gangi A, Ravikumar J.
Trends
in the Incidence of Brain Cancer: An Observational Study.
Cureus.
2024 Oct 31;16(10):e72805. doi:
10.7759/cureus.72805. PMID:
39618616. Observational study. ˍ
Zarco N, Dovas A, de Araujo Farias V, Nagaiah NKH, Haddock A, Sims
PA, Hambardzumyan D, Meyer CT, Canoll P, Rosenfeld SS, Kenchappa
RS.
Resistance to spindle inhibitors
in glioblastoma depends on STAT3 and therapy induced senescence.
iScience.
2024 Nov 5;27(12):111311. doi:
10.1016/j.isci.2024.111311. PMID:
39640583. Laboratory investigation. ˍ
Østergaard DE, Embring A, Sehested A, Magelssen H, Vogelius
IR, Kjærsgaard M, Nysom K, Mathiasen R, Lukacova S, Maraldo
MV.
REMIT: Reirradiation of Diffuse
Midline Glioma Patients -A Nordic Society of Paediatric
Haematology and Oncology Feasibility Study.
Clin
Oncol (R Coll Radiol). 2024 Nov 6;37:103682. doi:
10.1016/j.clon.2024.103682. PMID:
39626445. Interventional study protocol. ˍ
Nomura N, Nagasaka S, Suzuki K, Yamamoto J.
Imaging-tracked
progression of primary leptomeningeal gliomatosis: A case report.
Surg
Neurol Int. 2024 Nov 8;15:411. doi:
10.25259/SNI_759_2024. PMID:
39640309. Case report. ˍ
*Inoue H, Kuroda JI, Fujioka Y, Hata N, Mizoguchi M, Yoshii D,
Sueyoshi H, Takeshima Y, Fujimoto K, Shinojima N, Sunami K, Mikami
Y, Nakamura H, Mukasa A.
Drug-resistant
BRAF V600E-mutant recurrent pleomorphic xanthoastrocytoma, CNS WHO
Grade 3 successfully resolved with incidental discontinuation of
combined BRAF and MEK inhibitor therapy.
Surg
Neurol Int. 2024 Nov 15;15:417. doi:
10.25259/SNI_734_2024. PMID:
39640311. Case report. ˍ
*Elia A, Roux A, Trancart B, Moiraghi A, Seneca M, Dezamis E,
Varlet P, Chretien F, Oppenheim C, Zanello M, Pallud J.
Watch-and-wait approach versus
adjuvant treatment after radical awake resection in selected
adult-type grade 3 gliomas, isocitrate
dehydrogenase mutant: A
case-matched cohort.
Neurooncol
Adv. 2024 Nov 18;6(1):vdae189. doi:
10.1093/noajnl/vdae189. PMID: 39620200.
Observational study. ˍ
Turco L, Della Monica R, Giordano P, Cuomo M, Biazzo M, Mateu B,
Di Liello R, Daniele B, Normanno N, De Luca A, Rachiglio AM,
Chiaramonte C, Giugliano FM, Chiariotti L, Catapano G, Coretti L,
Lembo F.
Case report: Tracing in
parallel the salivary and gut microbiota profiles to assist
Larotrectinib anticancer treatment for NTRK
fusion-positive glioblastoma.
Front
Oncol. 2024 Nov 20;14:1458990. doi:
10.3389/fonc.2024.1458990. PMID:
39634265. Case report. ˍ
Garcia DG, Casas MÁG, Martínez MHG.
Gliomatosis
Cerebri Manifested as Parkinsonism Syndrome: A Case Report.
Case
Rep Neurol Med. 2024 Nov 28;2024:3375867. doi:
10.1155/crnm/3375867. PMID:
39641121. Case report. ˍ
Qiu Y, Li Y, Cuihong J, Wu X, Liu W, Fan C, Ye X, He L, Xiao S,
Zhao Q, Wu W, Chen K, Tan C, Li Y, Wang H, Liu F.
Toxicity
and Efficacy of Different Target Volume Delineations of
Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in
Patients with Grade 3-4 Glioma: A Randomized Controlled Clinical
Trial.
Int
J Radiat Oncol Biol Phys. 2024 Nov
28:S0360-3016(24)03668-X. doi:
10.1016/j.ijrobp.2024.11.094. PMID:
39615657. Interventional study˰
ˍ
Wang Y, Sun L, Di G, Jiang X.
Post-traumatic
glioma: Report of one case.
Asian
J Surg. 2024 Nov 29:S1015-9584(24)02742-8. doi:
10.1016/j.asjsur.2024.11.116. PMID:
39616052. Case report. ˍ